PwC as Deals Manager – Entrepreneurial and Venture Capital Business at NextLevel.
Prior to joining PwC, Golnaz was an associate partner at Ventac Partners, life science-dedicated venture catalyst and consulting firm with offices in Europe, US and China. Ventac Partners has built and managed portfolio companies with combined value of $1 billion in biotech, medtech and pharma.
Golnaz is specialised in business development of early stage life science companies, both pre- and post-IPO, business intelligence, partnerships and fundraising. Golnaz has also been advisor to family offices and venture capitals on business evaluation and technology and market assessment for heath-tech investment opportunities.
Dr Borghei is certified from Harvard Business School in executive finance, and is specialised in financial valuation of early stage life science companies through building business cases, risk and scenario analysis and similar deal-terms and transactions.
Golnaz has received her PhD from University of Cambridge in Analytical Biotechnology, followed by postdoc at Oxford and Cambridge Universities in Neuroscience and electrophysiology. She has led several research/industry collaborations focused on drug and device development in which she managed international collaborations. Among Golnaz’ publications are book chapters for NATO Science book series for Peace and Security and front cover of Analyst.
Lived and worked in the UK, North Europe and the Middle East, Golnaz has a global perspective to entrepreneurship and has been a jury member, lecturer and mentor for a number of life science start-up across the globe.
Her favourite quotation is from IBM CEO, Ginni Rometty: “Growth And Comfort Don’t Co-Exist”